Control of arg-2 Gene Expression in Neurospora

描述（由申请人提供）：这项工作的目标是了解上游开放阅读框（uORF）编码的肽如何控制mRNA上核糖体的运动并调节基因表达。精氨酸衰减肽（AAP）由mRNA中的uORF编码，其指定真菌精氨酸（Arg）生物合成酶，并且当Arg高时降低基因表达。AAP介导的调节在体外观察使用提取物从真菌和小麦胚芽。新生的AAP导致核糖体响应于Arg而停滞。停滞的核糖体阻断了进入下游起始克隆的通路，而起始克隆启动酶的合成。AAP是一种独特的真核生物肽，因为它的合成可以阻止参与终止和延伸的核糖体。它的研究提供了特殊的机会，检查中央翻译过程，仍然不理解。它将为评价干扰翻译的抗生素的功能提供有关核糖体内事件的有价值的信息。由于在动物、植物、真菌、病毒和细菌中发现了控制基因表达的uORF，因此所提出的工作与理解这些重要的调控元件直接相关。在一个调控的工作模型中，新生的AAP通过采用一种构象来阻止核糖体，该构象与Arg一起干扰核糖体A位点的解码，或干扰对翻译至关重要的其他步骤。拟议的研究将测试和完善AAP介导的调节模型。具体目标是：1。通过（a）确定停滞的核糖体是否含有与tRNA共价连接的新生AAP以确定肽基转移酶活性是否被阻断，（B）使用新生链与核糖体的光交联以检查新生AAP与核糖体之间响应于Arg的相互作用中的构象变化，（c）使用Arg类似物的光交联来确定Arg是否与AAP或与翻译机制相互作用，以及（d）确定调节是否仅需要在原核生物和真核生物之间保守的翻译组分。2.检查无义介导的mRNA衰变（NMD）中的突变对mRNA稳定性和AAP终止密码子识别的影响。NMD突变消除了uORF编码的AAP在体内的调节。3.通过检查真菌中影响Arg特异性调节或体内翻译的突变对体外AAP介导的核糖体停滞的影响，确定对翻译控制重要的其他反式作用基因。基因的克隆和鉴定及其功能分析应该为突变提供合理的解释。4.通过对停滞位点的突变分析，结合使用影响翻译的抗生素和影响调控的反式作用突变体，深入了解调控功能。

DESCRIPTION (provided by applicant): The goal of this work is to understand how a peptide encoded by an upstream open reading frame (uORF) controls the movement of ribosomes on mRNA and regulates gene expression. The arginine attenuator peptide (AAP) is encoded by a uORF in mRNAs specifying a fungal arginine (Arg) biosynthetic enzyme and reduces gene expression when Arg is high. AAP-mediated regulation is observed in vitro using extracts from fungi and wheat germ. The nascent AAP causes the ribosome to stall in response to Arg. Stalled ribosomes block access to the downstream start coclon that initiates enzyme synthesis. The AAP is a unique eukaryotic peptide because its synthesis can arrest ribosomes involved in both termination and elongation. Its study provides exceptional opportunities to examine central translational processes that are still not understood. It will provide valuable information on events within the ribosome for evaluating the functions of antibiotics that interfere with translation. Since uORFs that control gene expression are found in animals, plants, fungi, viruses and bacteria, the proposed work is directly relevant to understanding these important regulatory elements.In a working model for regulation, the nascent AAP stalls the ribosome by adopting a conformation that, with Arg, interferes with decoding at the ribosomal A site, or with other steps crucial for translation. The proposed studies will test and refine models for AAP-mediated regulation. Specific aims are: 1. Directly examine the regulatory mechanism by (a) establishing whether stalled ribosomes contain the nascent AAP covalently linked to tRNA to determine whether peptidyl transferase activity is blocked, (b) using photocross-linking of the nascent chain to the ribosome to examine conformational changes in the interaction between the nascent AAP and the ribosome in response to Arg, (c) using photocros s-linking of Arg analogs to determine whether Arg interacts with the AAP or with the translational machinery, and (d) determining whether regulation requires only translational components conserved between prokaryotes and eukaryotes. 2. Examine mutations in nonsense-mediated mRNA decay (NMD) for their effects on mRNA stability and AAP-termination codon recognition. NMD mutations eliminate regulation by the uORF-encoded AAP in vivo. 3. Identify additional trans-acting genes important for translational control by examining mutations in fungi that affect Arg-specific regulation or translation in vivo for their effects on AAP-mediated ribosome stalling in vitro. Cloning and identification of the genes and analysis of their functions should provide a rational explanation of the mutations. 4. Obtain an in-depth understanding of regulatory function by mutational analysis of stalling sites in combination with the use of antibiotics affecting translation and trans-acting mutants affecting regulation.